Southeast AIDS Education and Training Center (SE AETC) | 615-875-7873

Presentations

Click a title below to download the presentation slides in PDF.

Pre-Exposure Prophylaxis

Anna Person, MD

Objectives:

  • Importance of PrEP in the Southeast
  • Provider barriers for providing PrEP
  • Becoming a PrEP provider
  • Logistical considerations of a PrEP clinic
    • Visits
    • Labs
    • Truvada®
    • Advertising

Transgender Cultural Competency

Anna Person, MD

Objectives:

  • Be familiar with appropriate terminology.
  • Discuss issues related to HIV infection within the
    transgender community.
  • Be acquainted with basic health maintenance issues.
  • Basics on hormone therapy and surgical options.

STI Overview

Amen Eguakun, FNP

Objectives:

  • Identify the impact of sexually transmitted infections
    (STIs) on the acquisition of HIV infection
  • Identify symptoms suggestive of sexually transmitted
    infection (STI)
  • Choose appropriate diagnostic tests for sexually
    transmitted infection
  • Treat sexually transmitted infections according to
    guideline recommendations

First Line HIV Therapy

David Cluck, PharmD, BCPS, AAHIVP

Objectives:

  • Select an appropriate antiretroviral regimen
    in a treatment naïve patient
  • Recognize factors which should be taken into
    consideration when selecting an initial regimen

ART Updates

David Cluck, PharmD, BCPS, AAHIVP

Objectives:

  • Recall newly approved antiretrovirals and
    their respective place in therapy
  • Discuss emerging data on new antiretrovirals
    that are likely to be approved for clinical use

Talking With Clients About Sexual Health

Evelyn Tomaszewski, MSW, ACSW

Objectives:

  • Learn the practitioner roles in addressing sexual health in behavioral
    health care
  • Review the evidence on the impact of the providers’ and the youth’s
    cultural context, life experiences, and health literacy on assessment
    and dialog.
  • Practice tools for assessing sexual health and health risk behaviors for
    use in peer support models and wrap around services.
  • Learn available evidence-based risk and harm reduction strategies that
    improve health outcomes.

Pretreatment Evaluation

Cody Chastain, MD

Objectives:

  • Outline the appropriate evaluation of a person infected
    with HCV in order to assess the benefits and risks of
    treatment and in anticipation of treatment with direct
    acting antiviral therapy

HCV Treatment Selection

Cody Chastain, MD

Objectives:

  • Describe the history of HCV treatment options
  • Discuss past and current direct acting antiviral (DAA)
    therapies for HCV
  • Navigate treatment selection for patients with HCV

Pharmacologic Considerations of HCV Treatment

Autumn Zuckerman, PharmD, BCPS, AAHIVP

Objectives:

  • Review pharmacokinetic properties of currently utilized
    Hepatitis C medications
  • Review drug interactions and drug elimination
    considerations resulting from pharmacokinetic properties
  • Discuss practical management of drug interactions and
    drug elimination

From Prescription to Patient: Navigating Barriers to HCV Treatment Initiation

Autumn Zuckerman, PharmD, BCPS, AAHIVP

Objectives:

  • Describe the financial impact of HCV treatment on the
    healthcare system.
  • Identify current restrictions to HCV treatment common among
    third party payers
  • Illustrate successful navigation through the prior authorization
    and appeal process
  • Review criteria and options for patient assistance programs
    (PAP)
  • Discuss ancillary financial and treatment assistance available

HCV Treatment Monitoring & Post Treatment Surveillance

Cody Chastain, MD

Objectives:

  • Monitor HCV treatment as per guideline
    recommendations
  • Recommend appropriate long-term care of liver disease
    subsequent to HCV sustained virologic response

The Opioid Epidemic in Tennessee

Sarah T. Melton, PharmD, BCPP, BCACP, FASCP

Objectives:

  • Describe the scope and epidemiology of the opioid public health
    emergency in Tennessee and on the national level
  • Discuss the diagnostic criteria for opioid use disorder (OUD)
  • Compare the different medications used to treat OUD and opioid
    overdose
  • Interpret recent updated prescribing guidelines in Tennessee
    related to the treatment of OUD, chronic pain, and co-prescribing
    of naloxone
  • Explain methods of educating patients with substance use
    disorders (SUD) and ways of decreasing stigma.

Additional Resources

ART
Resources

[display-posts order=”ASC” orderby=”title” taxonomy=”category” tax_term=”hrsa, medications, resources” taxonomy_2=”post_tag” tax_2_term=”art, arv, art/arv, antiretroviral-treatment, antiretroviral-therapy, antiretroviral-drugs, antiretroviral”]

Presentations

[display-posts order=”ASC” orderby=”title” taxonomy=”category” tax_term=”webcast” taxonomy_2=”post_tag” tax_2_term=”art, arv, art/arv, antiretroviral-treatment, antiretroviral-therapy, antiretroviral-drugs, antiretroviral”]

Cultural Competency
Resources

[display-posts order=”ASC” orderby=”title” taxonomy=”category” tax_term=”hrsa, hiv-101-and-continuum-of-care” taxonomy_2=”post_tag” tax_2_term=”cultural-competency, cultural-competence, culture, cultural, competency, competence”]

Presentations

[display-posts order=”ASC” orderby=”title” taxonomy=”category” tax_term=”webcast” taxonomy_2=”post_tag” tax_2_term=”cultural-competency, cultural-competence, culture, cultural, competency, competence”]

HCV
Resources

[display-posts order=”ASC” orderby=”title” taxonomy=”category” tax_term=”hrsa, coinfections-and-opportunistic-infections-(ois)” taxonomy_2=”post_tag” tax_2_term=”hepatitis-c, hepc, hep-c, hcv”]

Presentations

[display-posts order=”ASC” orderby=”title” taxonomy=”category” tax_term=”webcast” taxonomy_2=”post_tag” tax_2_term=”hepatitis-c, hepc, hep-c, hcv”]

PrEP
Resources

[display-posts order=”ASC” orderby=”title” taxonomy=”category” tax_term=”hrsa, prevention” taxonomy_2=”post_tag” tax_2_term=”prep, pre-exposure-prophylaxis”]

Presentations

[display-posts order=”ASC” orderby=”title” taxonomy=”category” tax_term=”webcast” taxonomy_2=”post_tag” tax_2_term=”prep, pre-exposure-prophylaxis”]

Substance Abuse
Resources

[display-posts order=”ASC” orderby=”title” taxonomy=”category” tax_term=”hrsa, primary-care” taxonomy_2=”post_tag” tax_2_term=”substance-abuse, substance, drugs, abuse, addiction”]

Presentations

[display-posts order=”ASC” orderby=”title” taxonomy=”category” tax_term=”webcast” taxonomy_2=”post_tag” tax_2_term=”substance-abuse, substance, drugs, abuse, addiction”]

Transgender
Resources

[display-posts order=”ASC” orderby=”title” taxonomy=”category” tax_term=”hrsa” taxonomy_2=”post_tag” tax_2_term=”transgender”]

Presentations

[display-posts order=”ASC” orderby=”title” taxonomy=”category” tax_term=”webcast” taxonomy_2=”post_tag” tax_2_term=”transgender”]